Emvision Medical Devices Ltd Total Assets
Emvision Medical Devices Ltd total assets. Based on the latest financial reports, Emvision Medical Devices Ltd (EMV) holds total assets worth AU$24.94 Million AUD (≈ $17.65 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see market value of Emvision Medical Devices Ltd for the company's overall valuation and market capitalisation.
Total Assets of Emvision Medical Devices Ltd (2018–2025)
Total assets of Emvision Medical Devices Ltd from 2018 to 2025. This chart illustrates how Emvision Medical Devices Ltd's total assets have evolved over time, based on quarterly financial data. See today's stock price for Emvision Medical Devices Ltd for real-time trading data and today's change.
Emvision Medical Devices Ltd - Asset Composition Analysis
Emvision Medical Devices Ltd Total Assets Breakdown (June 2025)
Emvision Medical Devices Ltd total assets breakdown as of June 2025. Emvision Medical Devices Ltd's total assets of AU$24.94 Million consist of 89.5% current assets and 10.5% non-current assets.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 67.1% |
| Accounts Receivable | AU$3.18 Million | 20.5% |
| Inventory | AU$0.00 | 0.0% |
| Property, Plant & Equipment | AU$1.03 Million | 6.6% |
| Intangible Assets | AU$605.25K | 3.9% |
| Goodwill | AU$0.00 | 0.0% |
Asset Composition Trend (2018–2025)
This chart illustrates how Emvision Medical Devices Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore EMV net working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Emvision Medical Devices Ltd's current assets represent 89.5% of total assets in 2025, an increase from 70.3% in 2018.
- Cash Position: Cash and equivalents constituted 67.1% of total assets in 2025, up from 63.1% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, a decrease from 29.0% in 2018.
- Asset Diversification: The largest asset category is accounts receivable at 20.5% of total assets.
Emvision Medical Devices Ltd Competitors by Total Assets
Key competitors of Emvision Medical Devices Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
BMC Medical Co. Ltd. A
SHE:301367
|
China | CN¥3.59 Billion |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $96.98 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
Hironic Co. Ltd
KQ:149980
|
Korea | ₩80.01 Billion |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩131.65 Billion |
|
Oncosil Medical Ltd
AU:OSL
|
Australia | AU$7.13 Million |
Emvision Medical Devices Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 12.94 | 8.56 | 11.93 |
| Quick Ratio | 12.94 | 8.56 | 11.93 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | AU$21.65 Million | AU$15.26 Million | AU$12.13 Million |
Emvision Medical Devices Ltd - Advanced Valuation Insights
This section examines the relationship between Emvision Medical Devices Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 8.98 |
| Latest Market Cap to Assets Ratio | 6.04 |
| Asset Growth Rate (YoY) | -35.0% |
| Total Assets | AU$15.57 Million |
| Market Capitalization | $94.04 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Emvision Medical Devices Ltd's assets at a significant premium (6.04x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Emvision Medical Devices Ltd's assets decreased by 35.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Emvision Medical Devices Ltd (2018–2025)
The table below shows the annual total assets of Emvision Medical Devices Ltd from 2018 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | AU$15.57 Million ≈ $11.02 Million |
-35.03% |
| 2024-06-30 | AU$23.97 Million ≈ $16.96 Million |
+108.13% |
| 2023-06-30 | AU$11.52 Million ≈ $8.15 Million |
+35.39% |
| 2022-06-30 | AU$8.51 Million ≈ $6.02 Million |
-21.04% |
| 2021-06-30 | AU$10.77 Million ≈ $7.62 Million |
+79.16% |
| 2020-06-30 | AU$6.01 Million ≈ $4.26 Million |
+18.77% |
| 2019-06-30 | AU$5.06 Million ≈ $3.58 Million |
+213.57% |
| 2018-06-30 | AU$1.61 Million ≈ $1.14 Million |
-- |
About Emvision Medical Devices Ltd
EMVision Medical Devices Ltd engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia. It offers non-invasive brain scanners, including emu Brain Scanner, a bedside device; and First Responder Brain Scanner, a device embedded in standard road and air ambulances to deliver pre-hospita… Read more